Literature DB >> 15451563

Modulation of activin and BMP signaling.

Craig A Harrison1, Ezra Wiater, Peter C Gray, Jason Greenwald, Senyon Choe, Wylie Vale.   

Abstract

Activins and bone morphogenetic proteins (BMPs) elicit diverse biological responses by signaling through two pairs of structurally related types I and II receptors. Here, we summarize recent advances in understanding the mode of action of activins and BMPs, focusing on our elucidation of the crystal structure of BMP-7 in complex with the extracellular domain (ECD) of the activin type II receptor and our identification of a binding site for activin on the type I receptor ALK4. As a consequence of the broad range of activities of activins and BMPs, it is perhaps not surprising that additional mechanisms are continually being discovered through which a cell's responsiveness to these ligands is modulated. In this review, we describe novel ways in which the two extracellular cofactors, betaglycan and Cripto, regulate BMP and/or activin signal transduction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451563     DOI: 10.1016/j.mce.2004.02.008

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

Review 1.  Challenges in the study of neuronal differentiation: a view from the embryonic eye.

Authors:  Ruben Adler
Journal:  Dev Dyn       Date:  2005-11       Impact factor: 3.780

2.  Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.

Authors:  Malcolm Whitman; Vicki Rosen; Ali H Brivanlou; Jay C Groppe; Walter Sebald; Thomas Mueller
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

3.  The Local Control of the Pituitary by Activin Signaling and Modulation.

Authors:  Louise M Bilezikjian; Wylie W Vale
Journal:  Open Neuroendocrinol J       Date:  2011-01-01

Review 4.  The RGM/DRAGON family of BMP co-receptors.

Authors:  Elena Corradini; Jodie L Babitt; Herbert Y Lin
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-07       Impact factor: 7.638

5.  The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization.

Authors:  Qi Shen; Shawn C Little; Meiqi Xu; Julia Haupt; Cindy Ast; Takenobu Katagiri; Stefan Mundlos; Petra Seemann; Frederick S Kaplan; Mary C Mullins; Eileen M Shore
Journal:  J Clin Invest       Date:  2009-10-12       Impact factor: 14.808

6.  NDRG2 Promotes GATA-1 Expression through Regulation of the JAK2/STAT Pathway in PMA-stimulated U937 Cells.

Authors:  Kyeongah Kang; Hyeyoun Jung; Sorim Nam; Jong-Seok Lim
Journal:  Immune Netw       Date:  2011-12-31       Impact factor: 6.303

7.  Activin A balance regulates epithelial invasiveness and tumorigenesis.

Authors:  Grégoire F Le Bras; Holli A Loomans; Chase J Taylor; Frank L Revetta; Claudia D Andl
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

8.  Partial promoter substitutions generating transcriptional sentinels of diverse signaling pathways in embryonic stem cells and mice.

Authors:  Palle Serup; Carsten Gustavsen; Tino Klein; Leah A Potter; Robert Lin; Nandita Mullapudi; Ewa Wandzioch; Angela Hines; Ashley Davis; Christine Bruun; Nina Engberg; Dorthe R Petersen; Janny M L Peterslund; Raymond J Macdonald; Anne Grapin-Botton; Mark A Magnuson; Kenneth S Zaret
Journal:  Dis Model Mech       Date:  2012-08-10       Impact factor: 5.758

9.  Structure of Gremlin-1 and analysis of its interaction with BMP-2.

Authors:  Miglė Kišonaitė; Xuelu Wang; Marko Hyvönen
Journal:  Biochem J       Date:  2016-04-01       Impact factor: 3.857

10.  Two-day-treatment of Activin-A leads to transient change in SV-HFO osteoblast gene expression and reduction in matrix mineralization.

Authors:  Marta Baroncelli; Ksenija Drabek; Marco Eijken; Bram C J van der Eerden; Jeroen van de Peppel; Johannes P T M van Leeuwen
Journal:  J Cell Physiol       Date:  2019-10-30       Impact factor: 6.384

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.